Caspase 8 is the most proximal caspase in the caspase cascade and has been known for its role in the mediation of cell death by various death receptors belonging to the TNFR family. We have discovered that Caspase 8 can activate the NF-kB pathway independent of its activity as a pro-apoptotic protease. This property is localized to its N-terminal prodomain, which contains two homologous death eector domains (DEDs). Caspase 10 and MRIT, two DEDs-containing homologs of Caspase 8, can similarly activate the NF-kB pathway. Dominantnegative mutants of the Caspase 8 prodomain can block NF-kB induced by Caspase 8, FADD and several death receptors belonging to the TNFR family. Caspase 8 can interact with multiple proteins known to be involved in the activation of the NF-kB pathway, including the serine-threonine kinases RIP, NIK, IKK1 and IKK2. Thus, DEDs-containing caspases and caspase homolog(s) may have functions beyond their known role in the mediation of cell death. Oncogene (2000) 19, 4451 ± 4460.
Introduction
Tumor Necrosis Factor Receptor 1 (TNFR1) is the best characterized death receptor of the TNFR family (Ashkenazi and Dixit, 1998; Baker and Reddy, 1996) . On ligand induced aggregation, death domain of TNFR1 binds the homologous domain of TRADD, a death domain-containing cytoplasmic adaptor protein (Hsu et al., 1995 Varfolomeev et al., 1996) . TRADD subsequently activates a kinase cascade, consisting of the NF-kB and JNK/SAPK pathways, via the recruitment of death domain-containing protein RIP (Receptor Interacting Protein) and TRAF2, which lacks a death domain (TNF Receptor Associated Factor 1). TRADD also activates a caspase cascade via the recruitment of FADD/MORT1, another adaptor protein, which possesses a C-terminal death domain and an N-terminal`death eector domain' (Boldin et al., 1995; Chinnaiyan et al., 1995 Chinnaiyan et al., , 1996 Hsu et al., 1996; Varfolomeev et al., 1996) . The DED of FADD binds to the N-terminal prodomain of Caspase 8 (also called FLICE, MACH or Mch5), a proapoptotic apical caspase of the caspase cascade Fernandes-Alnemri et al., 1996; Muzio et al., 1996) . The prodomain of Caspase 8 consists of two homologous DEDs and serves to keep Caspase 8 in an inactive form (Chinnaiyan and Dixit, 1997) . DEDscontaining prodomains are also found in two additional cellular proteins; Caspase 10 (Mch4, FLICE2), a proteolytically active Caspase 8 homolog (FernandesAlnemri et al., 1996; Vincenz and Dixit, 1997) , and MRIT (Casper, c-FLIP, I-FLICE, FLAME, CASH, CLARP), a Caspase 8 homolog which is devoid of protease activity (Goltsev et al., 1997; Han et al., 1997; Hu et al., 1997; Inohara et al., 1997; Irmler et al., 1997; Shu et al., 1997; Srinivasula et al., 1997) .
In the present study present evidence that the DEDs of Caspase 8 and its homologs are also involved in the activation of the NF-kB pathway. Our study suggests the existence of a functional and biochemical link between the caspase and the kinase cascades downstream of the adaptor molecule TRADD and indicates that Caspase 8 and its homologs have roles beyond their activity as cell death proteases.
Results

Caspase 8 activates NF-kB
We began by testing the ability of Caspase 8 to activate an NF-kB-driven luciferase reporter construct in 293T cells (Berberich et al., 1994) . Expression of Caspase 8 in these cells had no major toxicity and led to signi®cant activation of the NF-kB/luciferase reporter construct in a dose-and time-dependent manner (Figure 1a ± c). Caspase 8 failed to activate luciferase reporter constructs driven by mutant NF-kB binding-sites, NF-IL6 or NFAT, which demonstrated the speci®city of the assay ( Figure 1a and data not shown). The NF-kB inducing ability of Caspase 8 was not limited to the 293T cells since it activated NF-kB in the MCF7 and 293 EBNA cells as well (Figure 1d and data not shown). The ability of Caspase 8 to activate the NF-kB pathway was further con®rmed by an electrophoretic mobility shift assay, which also con®rmed the speci®city of this response (Figure 1e ). However, Caspase 8 was a relatively weaker stimulator of the NF-kB pathway as compared to TNFR1 (Figure 1e ).
The prodomain of Caspase 8 mediates NF-kB activation
The observed ability of Caspase 8 to activate the NFkB pathway could be secondary to its ability to activate the cell death pathway and the resultant activation of stress-response genes. To separate the NF-kB inducing ability of Caspase 8 from its ability to act as a pro-apoptotic caspase, we tested the ability of various deletion and point mutants of Caspase 8 to activate the NF-kB pathway.
A construct encoding the full-length prodomain of Caspase 8, containing its two Death Eector Domains (DEDs) (amino acids 1 ± 180), was able to activate NFkB to an even greater extent than the full-length Caspase 8, whereas deletion constructs encoding either DED1 (aa 1 ± 103) or DED2 (aa 104 ± 180) alone failed to do so (Figure 2) . Similarly, constructs encoding the full-length protease (caspase homology) domain or the individual p20 or p10 sub-domains failed to activate NF-kB (Figure 2 and data not shown). Caspase 8 C360S, which contains a cysteine to serine mutation at the catalytically active site and is, therefore, proteolytically inactive, was as eective as the wild-type Caspase 8 in activating the NF-kB pathway (Figure 2 ).
Ability of other caspases to activate NF-kB
We also tested the ability of several other caspase family members to activate the NF-kB pathway. Unlike Caspase 8, over-expression of Caspase 10 (Mch4 isoform) led to massive apoptosis in 293T cells but failed to induce NF-kB (Figure 3a and data not . After 16 h, nuclear extracts were prepared essentially as described previously (Yeh et al., 1997) . Nuclear extracts (2 mg) were incubated for 30 min at room temperature with a 32 P-labeled NF-kB duplex oligonucleotide (Promega, Madison, WI, USA) in a buer containing 10 mM HEPES (pH 7.9); 50 mM KCl, 0.2 mM EDTA, 2.5 mM DTT, 2 mg poly (dC:dI), 10% glycerol and 0.5% NP-40. Competition was carried out with 100-fold excess of cold NF-kB oligo duplex or a non-speci®c oligo duplex. Protein-DNA complexes were resolved on a 5% native polyacrylamide and run in Tris-glycine buer. Gel was dried and autoradiographed. The position of the induced NF-kB complex is marked by an arrow while * marks the position of a constitutive NF-kB complex. shown). However, its active site mutant (Caspase 10 C358A) failed to induce apoptosis and led to signi®cant induction of NF-kB ( Figure 3a and data not shown). Similarly, over-expression of MRIT led to signi®cant activation of NF-kB in the 293T cells and this activity was localized to its DEDs-containing prodomain ( Figure 3b and data not shown). Collectively, these results con®rm that the NF-kB induction by Caspase 8 and its homologs is dependent on their DEDs-containing prodomains and is independent of their protease ability.
Next we sought to determine whether non-DEDscontaining caspases, such as Caspases 1, 2, 3, 6, 7 and 9, could activate NF-kB in the 293T cells. As shown in Figure 3c , none of these other caspase family members was able to activate NF-kB, thereby con®rming the importance of DEDs in this process. Caspases 7 and 9 led to signi®cant cell death in the above assays. Therefore, this experiment was repeated with the active site mutants of these caspases that are incapable of inducing apoptosis. However, both Caspases 7 C186S and 9 C288S failed to activate NF-kB in the 293T cells as well (data not shown).
Effect of caspase inhibitors on NF-kB activation by Caspase 8 and its homologs
It may be postulated that the observed NF-kB inducing property of MRIT and the active site mutants of Caspases 8 and 10 is due to the ability of these proteins to oligomerize with the endogenously expressed wild-type caspases and the resultant activation of the caspase cascade. Similarly, the prodomain of Caspase 8 could potentially activate the caspase cascade by oligomerizing with the endogenously expressed full-length Caspase 8. To rule out this possibility, we tested the ability of CrmA and p35 to inhibit the NF-kB induced by Caspases 8, 10, and MRIT. CrmA is a cow-pox virus protein which is an inhibitor of the protease activity of proximal caspases while the baculovirus p35 protein is an inhibitor of the protease activity of both proximal and distal caspases. Both CrmA and p35 were ineective in blocking NF-kB activation by Caspases 8 or 10, thus con®rming that NF-kB activation by these caspases is independent of their ability to activate the caspase cascade ( Figure 3d) . Similarly, zVAD.fmk a broadspectrum cell-permeable peptide caspase inhibitor, was incapable of blocking Caspase 8-induced NF-kB activation ( Figure 3e) . Surprisingly, both CrmA and p35eectivelyabolishedNF-kBactivationbytheMRITa1 and MRITb1 isoforms ( Figure 3d and data not shown), which suggests that MRIT-induced NF-kB activation requires caspase activation. MRIT-a1-induced NF-kB was also blocked by zVAD-fmk (not shown).
Deletion and point mutants of DEDs act as dominant-negative inhibitors of NF-kB activation
To delineate the region(s) of the DEDs critical for the NF-kB inducing ability, we mutated three conserved residues in the DED1 of Caspase 8. The resulting mutants, termed D73A, L74A and L75A, have the amino-acid residues at positions 73, 74 and 75, respectively, changed to alanine ( Figure 4a ). Both D73A and L74A mutants failed to signi®cantly activate NF-kB, whereas L75A retained partial ability to do so ( Figure 4b ). Moreover, all three mutants partially inhibited NF-kB induction by full-length Caspase 8 and death receptors TNFR1, Fas/Apo1, DR3 and DR4 ( Figure 4c and data not shown). Similar results were obtained with an N-terminal deletion construct of Capase 8 (ND-Caspase 8) which is missing the Nterminal 63 amino acids (Figure 4b ). Taken together, these results suggest a role of Caspase 8 prodomain in the death receptors-induced NF-kB activation.
Inhibition of FADD-induced NF-kB activation by dominant-negative mutants of Caspase 8
We next tested the ability of FADD to activate the NF-kB pathway and the role of DEDs-containing proteins in this process. As shown in Figure 5a , overexpression of FADD led to ecient activation of NFkB in 293T cells and this was eectively blocked by the D73A mutant of Caspase 8. Furthermore, unlike a previous report (Liu et al., 1996) , FADD was highly eective in activating this pathway in MCF7 cells (Figure 5b ). In these cells, FADD was capable of activating NF-kB at a relatively low dose which had no signi®cant cytotoxicity (Figure 5b ). Taken together, these results suggest that FADD can activate the NFkB pathway and that Caspase 8 or its homologs may play a role in this process.
Mechanism(s) of Caspase 8-, 10-and MRIT-induced NF-kB activation
The serine-threonine kinases NIK and the IKKs have been shown to be involved in the activation of the NFkB pathway by the members of TNFR and ILIR families (DiDonato et al., 1997; Malinin et al., 1997; Mercurio et al., 1997; Regnier et al., 1997; Woronicz et al., 1997; Zandi et al., 1997) . To determine the role of these proteins in the Caspase 8-induced NF-kB activation, we took advantage of the dominant- Figure 2 Mutagenesis analysis of Caspase 8-induced NF-kB activation. Prodomain of Caspase 8 activates NF-kB. Experiment was performed as described for Figure 1a . C360S=Caspase 8 C360S mutant. PRO=Caspase 8 prodomain (aa 1 ± 180). DED1 and 2=Death Eector Domains 1 (aa 1 ± 103) and 2 (aa 104 ± 180) respectively. Protease domain=aa 217 ± 479. mTRAF2=-murine TRAF2. A representative (mean+s.e.m.) of three independent experiments performed in duplicate negative inhibitors of these kinases. As shown in Figure 6a , Caspase 8-induced NF-kB was eectively blocked by dominant-negative mutants of NIK (NIKD2101 and NIKK429R) and IKK2 (IKK2-K44A), whereas a similar mutant of IKK1 (IKK1-K44A) could do so only poorly. Caspase-induced NFkB activation was also eectively blocked by two phosphorylation-resistant mutants of IkBa (IkBDN and IkBa S32/36A) (Figure 6a ). Collectively, these results suggest that Caspase 8 activates NF-kB by NIK and IKK2 mediated phosphorylation of the IkB proteins. Finally, we investigated the role of TRAFs in the activation of NF-kB pathway by Caspase 8 and its homologs. An N-terminal deletion mutant of TRAF2 (Takeuchi et al., 1996) which has been previously shown to block NF-kB activation by various death receptors, was able to block NF-kB induction by all three DEDs-containing proteins (Figure 6b ). This dominant-negative TRAF2 construct could also inhibit NF-kB induction by the prodomain as well as the active site mutant of Caspase 8 (data not shown). However, an N-terminal deletion construct of TRAF5, which could block NF-kB activation by HVEM (Hsu et al., 1997) , failed to block NF-kB activation by Caspase 8 thereby demonstrating the speci®city of the response. These results suggest that TRAF2 may play a role in Caspase 8-mediated NFkB induction.
Caspases 8, 10 and MRIT interact with RIP, NIK and IKKs RIP was recently shown to be essential for TNFR1-mediated activation of the NF-kB pathway (Kelliher et al., 1998) . Therefore, to further elucidate the mechanism of Caspases 8-, 10-and MRIT-induced NF-kB activation, we tested their ability to physically interact with the serine-threonine protein kinase RIP. As shown in Figure 7a , Caspases 8, 10, MRIT a1 and b1 isoforms could coimmunoprecipitate RIP-HA but failed to coimmunoprecipitate GFP-HA, thereby demonstrating the speci®city of the interaction. This ability of Caspase 8 was localized to both the prodomain (aa 1 ± 180) and the caspase homology domain (aa 217 ± 479) (Figure 7b ). Caspases 8, 10 and MRIT could also coimmunoprecipitate with NIK whereas Caspase 3 failed to do so (Figure 7c ). Like the situation with RIP, both the prodomain and the protease domains of Caspase 8 could coimmunoprecipitate NIK (Figure 7d) .
We next tested the ability of the recently identi®ed IkB kinases, IKK1 and IKK2 to coimmunoprecipitate Caspase 8. As shown in Figure 7e , both IKK1 and IKK2 could successfully coimmunoprecipitate Caspase 8. IKK1 and IKK2 were also able to immunoprecipitate MRIT (data not shown). Unlike the situation with RIP and NIK, while the prodomain of Caspase 8 could interact with IKK2, the protease homology domain failed to do so (Figure 7f ). These results indicate that the interaction of the DEDs-containing prodomain with the IKKs may be crucial for the NF-kB induction by Caspase 8 and its homologs. (Figure 1e ), TNFR1 was a much stronger stimulator of the IKK kinase activity as compared with Caspase 8.
Discussion
In the present study, we have discovered that DEDscontaining proteins can physically and functionally interact with the proteins of the kinase cascade and activate the NF-kB pathway. Based on the available data, we will like to favor a model in which the NFkB-inducing property of Caspases 8, 10 and MRIT depends on their interactions with the protein kinases NIK, RIP and the IKKs. In addition to the above kinases, we have observed that the various DEDscontaining proteins can interact with multiple members of the TRAF family of adaptor proteins (Chaudhary et al., 1999) . While both the prodomain and the protease 5 cells were transfected with an empty vector or indicated amounts of FADD expression constructs along with an NF-kB/luciferase reporter construct (75 ng) and a RSV/LacZ reporter construct in duplicate. Thirtysix hours later, cells in one of the wells were ®xed and stained with X-gal to determine relative cytotoxicity according to previously described criteria . The luciferase activity was measured in cells from the other well and normalized relative to the b-galactosidase activity. Percentage cell death was as follows: Vector, 10%; FADD (100 ng), 15%; and FADD (500 ng) 22% An interesting result of our study was the ability of FADD to activate the NF-kB in the 293T and MCF7 cells. On the contrary, FADD was previously shown to be involved only in the mediation of apoptosis and was shown not to activate the NF-kB pathway in the MCF7 or the HeLa cells (Liu et al., 1996) . A possible explanation for the dierence between two groups of studies may lie in the use of cytotoxic concentration of FADD in the study by Liu et al., 1996 , which could have prevented the measurement of NF-kB activation due to premature death of transfected cells. However, alternative, and not entirely mutually exclusive, explanations for the above results are equally plausible. For example, under conditions favoring activation of the caspase cascade, receptor-bound Caspases 8/10 will be rapidly cleaved by cross-proteolysis and released from the DISC (Death Inducing Signaling Complex), preventing the recruitment and assembly of the NF-kBinducing complex (Figure 9a) . By preventing the activation of Caspases 8/10, proteins, such as CrmA, the TRAFs, the cIAPs or IEX-1L (depicted by Factor X), may allow these caspases to stay bound to the DISC, thereby providing sucient time for the assembly of the NF-kB inducing complex on them (Figure 9b) . Furthermore, the protease homology domain of Caspase 8 may also play a crucial role in NF-kB activation by recruiting and bringing RIP, NIK and TRAF2 to the prodomain-bound IKKs. There- Figure 8 Caspase 8 activates IKK kinase activity. 293T cells were transfected with the indicated plasmids and the cell lysate immunoprecipitated with a control (C) or an anti-Nemo polyclonal serum. The in vitro kinase reaction was performed using GST-IkBa as a substrate, as described in the Materials and methods section fore, it is conceivable that cleavage of Caspase 8 into its prodomain and the protease domain will lead to disruption of such a complex and inability to activate NF-kB. The above model might also explain how signaling through the death receptors might lead to cell death or proliferation depending on the cellular context ( Figure 9 ). Under conditions favoring caspase cleavage, NF-kB pathway will not be activated and the cell will commit to apoptosis. On the other hand, under the conditions which prevent caspase activation, signaling through the death receptors will activate the NF-kB pathway, which will not only promote cellular proliferation but also aord further protection against apoptosis by transcriptional activation of anti-apoptotic genes, such as the TRAFs, the IAPs and IEX-1L (Wang et al., 1998; Wu et al., 1998) .
The anti-apoptotic property of MRIT has been previously explained on the basis of its ability to compete with Caspases 8 or 10 to bind to the DED of FADD (Goltsev et al., 1997; Hu et al., 1997; Inohara et al., 1997; Irmler et al., 1997; Shu et al., 1997; Srinivasula et al., 1997) . Our results demonstrate the ability of this protein to activate the anti-apoptotic NF-kB pathway and thus provide an alternative/ additional mechanism for its ability to protect against cell death. Interestingly, activation of the NF-kB pathway has been also shown to promote cell death under certain conditions (Grimm et al., 1996; Hettmann et al., 1999; Jung et al., 1995; Lin et al., 1998) , which may explain the pro-apoptotic ability of MRIT as well.
The exact role of Caspase 8 and its homologs in the death domain receptors-induced NF-kB activation is not clear at present. These proteins may represent one of the several possible pathways for the induction of NF-kB by the death receptors. They may add to the overall NF-kB activation induced by the death receptors, resulting in a more robust activation of this pathway. Alternatively, they may play a role in TRAF2-independent delayed phase of NF-kB activation by the death receptors and thereby serve to prolong this response. Finally, the ability of Caspase 8 and FADD to activate the NF-kB pathway may be responsible for the observed defects in cardiac development and lymphocyte functions seen in mice containing the knock-out of these genes (Varfolomeev et al., 1998; Yeh et al., 1998) .
Materials and methods
Expression constructs
The expression constructs for the death receptors, RIP, FADD, CrmA, MRIT isoforms and the various caspases have been described previously Han et al., 1997) . Constructs encoding the p10 and p20 sub-units of Caspase 8, Caspases 1, 2, 3, 6, 7, and 9 were gifts from Michael Wright (University of Washington). Constructs encoding NIK and its mutants (Natoli et al., 1997) , IKKs and their mutants (Nakano et al., 1998) , IkBaDN and IkBaS32/36A (Brockman et al., 1995) , Caspase 10 (Mch4 isoform) and its C358A mutant (Fernandes-Alnemri et al., 1996) and NF-kB/luciferase reporter constructs (Berberich et al., 1994) have been described previously and were obtained from the indicated sources. The various point mutants of Caspases 8, 7, 9, 10 and MRIT were generated using the Quickchange site directed mutagenesis kit (Stratagene). The various deletion and fusion constructs were made by PCR using custom primers. Epitope-tagged expression constructs for Caspases 3, 7, 9, MRIT, RIP and their deletion and point mutants were tagged at the C-termini and the remaining constructs were tagged at the N-termini using custom primers. The sequence of all constructs was con®rmed by automated¯uorescent dye-terminator sequencing on an ABI 373 sequencing machine. Expression of all constructs was con®rmed by Western analysis on total cell extracts.
NF-kB luciferase reporter assay
For reporter gene assay, 1610 5 293T or MCF7 cells were seeded in each well of a 24-well tissue culture plate. Twenty-four hours later cells were transfected with the indicated amounts of various expression constructs along with an NF-kB/luciferase reporter construct (75 ng) and an RSV promoter driven b-galactosidase reporter construct (pRcRSV/LacZ) (75 ng) in duplicate. The NF-kB reporter plasmid contains four copies of an NF-kB binding site from the promoter of the invariant chain of MHC class II and has been described previously (Berberich et al., 1994) . The amount of test plasmid used was 750 ng/well for experiments involving a single test plasmid and 100 ng/well for those involving a test (activator) plasmid and an inhibitor plasmid. The amount of inhibitor plasmid used was 750 ng/ well and the total amount of transfected DNA was kept constant by adding empty vector. 293T cells were transfected using a calcium phosphate co-precipitation method, while MCF7 cells were transfected using Superfect (Qiagen) as described previously . Twenty to 24 h later cell extracts were prepared using the Luciferase Cell Culture Lysis Reagent (Promega, Madison, WI, USA) and luciferase assays performed using 20 ml of cell extract. The cell lysates were diluted 1 to 20 with Phosphate Buered Saline (pH=7.4) and used for the measurement of the b-galactosidase activity. Luciferase activity was normalized relative to the bgalactosidase activity to control for the dierence in the transfection eciency.
Coimmunoprecipitation assays
For studying in vivo interaction, 2610 6 293T cells were plated in a 100 mm plate and co-transfected 18 ± 24 h later with 5 mg/plate of each epitope-tagged constructs along 1 mg of a GFP encoding plasmid (pEGFP or HA-GFP) by calcium phosphate co-precipitation. Eighteen to 36 h post-transfection, cells were lysed in 1 ml of lysis buer containing 0.1% Triton X-100, 20 mM sodium phosphate (pH 7.4), 150 mM NaCl and 1 EDTA free mini-protease inhibitor tablet per 10 ml (Boehringer Mannheim). For immunoprecipitation, cells lysate (500 ml) was incubated for 1 h at 48C with 10 ml of FLAG or control mouse Ig beads precoated with 2% BSA. Beads were washed twice with lysis buer, twice with a wash buer containing 0.1% Triton X-100, 20 mm sodium phosphate (pH 7.4), 500 mM NaCl and again with lysis buer. Bound proteins were eluted by boiling, separated by SDS ± PAGE, transferred to a nitrocellulose membrane and analysed by Western blot.
In vitro kinase assay
Transiently transfected 293T cells were harvested 24 h post transfection. Cells were washed with cold PBS (pH 7.4) twice and lysed in 500 ml lysis buer containing 20 mM Tris pH 8.0, 0.5 M NaCl, 0.25% Triton X-100, 10 mM bglycophosphate, 10 mM NaF, 1 mM DTT and protease inhibitor cocktail (Roche). After 30-min incubation at 48C, supernatants were collected from centrifuge at 14 000 r.p.m. for 10 min. Protein concentration was determined using Bradford reagent at 600 nm. Immunoprecipitation was set up with 500 mg of each sample with either a control antibody or an anti-nemo / IKKg (Santa Cruz, FL-419) and carried out at 48C for 2 h. Immunoprecipitated proteins were collected by a brief spin. Beads were then washed three times with immunoprecipitation buer containing 40 mM Tris-HCl pH 8.0, 0.5 M NaCl, 0.1% NP-40, 6 mM EDTA, 10 mM b-glycophosphate, 10 mM NaF, 1 mM DTT, and protease inhibitor cocktail. Kinase reaction was performed in a buer containing 20 mM HEPES pH 7.6, 0.1 M KCl, 0.2 mM EDTA, 10% glycerol, 0.3 M MgCl 2 , 30 mM NaF, 30 mM b-glycophosphate, 0.15 M DTT, 1 mg BSA, 10 mM ATP, 10 mg GST-IkBa (1 ± 54), and 20 mCi [g-32 P]ATP (ICN, 35020) per reaction at 378C for 20 min. The reaction was stopped by the addition of 46SDS ± PAGE sample buer and samples resolved on a 12% SDS ± PAGE gel. After running, the gel was dried and autoradiographed.
